Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Heart Failure With Reduced Ejection Fraction
View Full LandscapeTarget Indication
Heart Failure With Reduced Ejection Fraction
Clinical Trial
NCT03759392Last updated: 1/2/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Kinharto
Treatment of adult patients with symptomatic chronic heart failure and reduced ejection fraction less than 30%
View on EMAHeart Failure
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Heart Failure